Literature DB >> 26342901

Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine.

Susan R Wilcox1, Christopher Kabrhel2, Richard N Channick3.   

Abstract

Pulmonary hypertension is a hemodynamic condition, defined as a mean pulmonary artery pressure by right-sided heart catheterization of at least 25 mm Hg at rest. It is classified into 5 general groups based on the underlying cause, with left ventricular failure and chronic obstructive pulmonary disease being 2 of the most common causes in the United States. Although the specifics of the pathophysiology will vary with the cause, appreciating the risks of pulmonary hypertension and right ventricular failure is critical to appropriately evaluating and resuscitating pulmonary hypertension patients in the emergency department (ED). Patients may present to the ED with complaints related to pulmonary hypertension or unrelated ones, but this condition will affect all aspects of care. Exertional dyspnea is the most common symptom attributable to pulmonary hypertension, but the latter should be considered in any ED patient with unexplained dyspnea on exertion, syncope, or signs of right ventricular dysfunction. Patients with right ventricular failure are often volume overloaded, and careful volume management is imperative, especially in the setting of hypotension. Vasopressors and inotropes, rather than fluid boluses, are often required in shock to augment cardiac output and reduce the risk of exacerbating right ventricular ischemia. Intubation should be avoided if possible, although hypoxemia and hypercapnia may also worsen right-sided heart function. Emergency physicians should appreciate the role of pulmonary vasodilators in the treatment of pulmonary arterial hypertension and recognize that patients receiving these medications may rapidly develop right ventricular failure and even death without these therapies. Patients may require interventions not readily available in the ED, such as a pulmonary artery catheter, inhaled pulmonary vasodilators, and mechanical support with a right ventricular assist device or extracorporeal membrane oxygenation. Therefore, early consultation with a pulmonary hypertension specialist and transfer to a tertiary care center with invasive monitoring and mechanical support capabilities is advised.
Copyright © 2015 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26342901     DOI: 10.1016/j.annemergmed.2015.07.525

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  11 in total

1.  Extracorporeal membrane oxygenation (ECMO) for acute exacerbations of chronic obstructive pulmonary disease: care modalities, experience, and precautions.

Authors:  Yaoji Wang; Pingping Cao
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 2.  Clinical mimics: an emergency medicine focused review of pneumonia mimics.

Authors:  Drew Alan Long; Brit Long; Alex Koyfman
Journal:  Intern Emerg Med       Date:  2018-03-26       Impact factor: 3.397

3.  Pulmonary Arterial Hypertension Emergency Complications and Evaluation: Practical Guide for the Advanced Practice Registered Nurses in the Emergency Department.

Authors:  Robin Hohsfield; Christine Archer-Chicko; Traci Housten; Stephanie Harris Nolley
Journal:  Adv Emerg Nurs J       Date:  2018 Oct/Dec

4.  VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese Population.

Authors:  Yufeng Zhuo; Qingchun Zeng; Peng Zhang; Guoyang Li; Qiang Xie; Ying Cheng
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

Review 5.  High-Risk Airway Management in the Emergency Department. Part I: Diseases and Approaches.

Authors:  Skyler Lentz; Alexandra Grossman; Alex Koyfman; Brit Long
Journal:  J Emerg Med       Date:  2020-05-12       Impact factor: 1.484

6.  Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.

Authors:  Changhong Cai; Yijia Xiang; Yonghui Wu; Ning Zhu; Huan Zhao; Jian Xu; Wensheng Lin; Chunlai Zeng
Journal:  Mol Med Rep       Date:  2019-10-30       Impact factor: 2.952

7.  Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry.

Authors:  Kris Bauchmuller; Robin Condliffe; Jennifer Southern; Catherine Billings; Athanasios Charalampopoulos; Charlie A Elliot; Abdul Hameed; David G Kiely; Ian Sabroe; A A Roger Thompson; Ajay Raithatha; Gary H Mills
Journal:  ERJ Open Res       Date:  2021-04-06

8.  Pulmonary tumor thrombotic microangiopathy presenting as recurrent syncope.

Authors:  Constanza Burciaga Calderoni; Dafne T Moretta; Jeanette Merrill-Henry; Paresh C Giri
Journal:  SAGE Open Med Case Rep       Date:  2020-10-26

9.  Physiologically Difficult Airway in the Patient with Severe Hypotension and Metabolic Acidosis.

Authors:  Joseph Capone; Vicko Gluncic; Anita Lukic; Kenneth D Candido
Journal:  Case Rep Anesthesiol       Date:  2020-09-04

10.  Burden of pulmonary arterial hypertension in England: retrospective HES database analysis.

Authors:  Fernando Exposto; Ruben Hermans; Åsa Nordgren; Luke Taylor; Sanam Sikander Rehman; Robert Ogley; Evan Davies; Amina Yesufu-Udechuku; Amélie Beaudet
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.